Calton & Associates’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-5,307
Closed -$293K – 392
2021
Q3
$293K Buy
5,307
+977
+23% +$58.8K 0.06% 290
2021
Q2
$259K Sell
4,330
-12,792
-75% -$811K 0.05% 319
2021
Q1
$599K Sell
17,122
-8,455
-33% -$467K 0.12% 167
2020
Q4
$723K Sell
25,577
-4,320
-14% -$187K 0.13% 140
2020
Q3
$858K Buy
29,897
+6,276
+27% +$238K 0.18% 104
2020
Q2
$618K Buy
23,621
+13,724
+139% +$478K 0.13% 128
2020
Q1
$276K Buy
9,897
+3,953
+67% +$175K 0.07% 219
2019
Q4
$268K Buy
+5,944
New +$287K 0.05% 284
2019
Q3
– Sell
-4,845
Closed -$205K – 351
2019
Q2
$205K Buy
+4,845
New +$228K 0.06% 262
2018
Q2
– Sell
-5,257
Closed -$241K – 353
2018
Q1
$241K Sell
5,257
-625
-11% -$30.3K 0.07% 288
2017
Q4
$315K Buy
+5,882
New +$310K 0.08% 233

Other funds holding MET

Calton & Associates's MET Position: Q4 2021 in Review

Calton & Associates sold out of MetLife (MET) in Q4 2021, closing a stake of 5,307 shares — an estimated $293K sold.

Calton & Associates first reported a position in MET in Q4 2017 and held it in 11 quarters. The position peaked at $858K in Q3 2020. 1,192 funds tracked by Wall St. Rank hold MET as of Q4 2021.

  • Calton & Associates reported no remaining MetLife position as of Q4 2021 after selling out during the quarter.
  • Calton & Associates sold 5,307 MetLife shares in Q4 2021, an estimated $293K.
  • Calton & Associates first reported a position in MetLife in Q4 2017 and held it in 11 quarters.
  • Calton & Associates's MetLife position peaked at $858K in Q3 2020.
  • 1,192 funds tracked by Wall St. Rank held MetLife as of Q4 2021.

Based on Calton & Associates's 13F filing for Q4 2021, filed 13 Jan 2022.